Insurance companies in the US are refusing to cover its use among people who are not diabetic and not taking it as a prescribed medicine
In clinical trials, for people with type 2 diabetes, people using Ozempic achieved weight loss ranging from around 7% to more than 12% of their initial body weight, on average
Individual responses vary, and switching formulations is worth discussing with your provider if bloating remains problematic
Most episodes were mild to moderate, and the median duration of individual nausea episodes was approximately 8 days
While Ozempic is primarily prescribed for managing type 2 diabetes on the NHS, its weight loss benefits have drawn attention, often leading to questions about its availability for non-diabetic purposes
DAC (Drug Affinity Complex) is a modification that lets the peptide bind to albumin in your blood, extending its half-life from ~30 minutes to ~8 days